RVMD FDA approves RASONQUE for metastatic pancreatic cancer
RVMD says the FDA approved RASONQUE and plans an immediate U.S. launch for metastatic pancreatic cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.